105 related articles for article (PubMed ID: 4929363)
1. The effect of nandrolone phenylpropionate (Durabolin) on the bone-marrow suppression caused by cyclophosphamide.
Cooke WM; Burn JI
Br J Surg; 1971 Apr; 58(4):302-3. PubMed ID: 4929363
[No Abstract] [Full Text] [Related]
2. Effect of nandrolone phenylpropionate (NSC-23162e) on the bone marrow suppression caused by cyclophosphamide (NSC-26271): a clinical trial.
Burn JI; Cooke WM
Cancer Chemother Rep; 1974; 58(6):867-70. PubMed ID: 4615786
[No Abstract] [Full Text] [Related]
3. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
Huys J; Van Vaerenbergh PM
Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
[No Abstract] [Full Text] [Related]
4. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
Berger J
Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
[TBL] [Abstract][Full Text] [Related]
5. Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
DiBenedetto J; Higby DJ; Chester SJ; Albala MM
J Med; 1980; 11(5-6):385-92. PubMed ID: 6962825
[TBL] [Abstract][Full Text] [Related]
6. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
Schubert JC; Ischer M; Hilbert L
Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
[No Abstract] [Full Text] [Related]
7. Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs.
Udupa KB; Reissmann KR
Cancer Res; 1974 Oct; 34(10):2517-20. PubMed ID: 4411809
[No Abstract] [Full Text] [Related]
8. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
Spiers AS; DeVita SF; Allar MJ; Richards S; Sedransk N
J Med; 1981; 12(6):433-45. PubMed ID: 7033426
[TBL] [Abstract][Full Text] [Related]
9. [Course of hematotoxic cyclophosphamide effects in the rat].
Werner W; Haller M; Höpfner V; Küchler J; Ziervogel J
Exp Pathol (Jena); 1971; 5(1):123-7. PubMed ID: 5098036
[No Abstract] [Full Text] [Related]
10. [The effect of the anabolic steroid nortestosterone phenylpropionate on the hematotoxic action of cyclophosphamide].
Fölsch E; Brügger W; Immich H
Verh Dtsch Ges Inn Med; 1967; 73():453-7. PubMed ID: 5591798
[No Abstract] [Full Text] [Related]
11. The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(3):281-7. PubMed ID: 7902635
[TBL] [Abstract][Full Text] [Related]
12. Trial with nandrolone phenylpropionate (Durabolin, Organon) on protein-calorie deficiency.
Pudjiadi SH; Nassa S; Kho LK; Rahaju N; Talogo W
Paediatr Indones; 1969; 9(3):110-6. PubMed ID: 5350279
[No Abstract] [Full Text] [Related]
13. Anabolic steroids and bone marrow toxicity during therapy with methotrexate.
Rawbone RG; Bagshawe KD
Br J Cancer; 1972 Oct; 26(5):395-401. PubMed ID: 4343678
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytic recovery after experimental suppression of haemopoiesis in the rat.
Berger J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):599-603. PubMed ID: 6083933
[TBL] [Abstract][Full Text] [Related]
15. The haemopoietic effect of nandrolone-phenylpropionate (Durabolin).
BOOIJ J; KUYPERS J
Acta Physiol Pharmacol Neerl; 1962; 11():12-9. PubMed ID: 13871124
[No Abstract] [Full Text] [Related]
16. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
[No Abstract] [Full Text] [Related]
17. Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
Cole MP; Todd ID; Wilkinson PM
Br J Cancer; 1973 May; 27(5):396-9. PubMed ID: 4576562
[TBL] [Abstract][Full Text] [Related]
18. Granulopoietic models--effect on chemotherapy.
Cronkite EP
N Engl J Med; 1970 Mar; 282(12):683-4. PubMed ID: 5437528
[No Abstract] [Full Text] [Related]
19. [Anabolic treatment combined with an antimitotic agent in order to prevent leukocyte decrease].
Biedermann C; Obolensky W; Scoglio P; Zürcher WO
Ther Umsch; 1966 Dec; 23(12):509-15. PubMed ID: 5980438
[No Abstract] [Full Text] [Related]
20. Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide.
Epstein RB; Storb R; Clift RA; Thomas ED
Cancer Res; 1969 May; 29(5):1072-5. PubMed ID: 4889109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
